About Remepy
Remepy is a company based in United States founded in 2022 by Michal Tsur. Remepy has raised $15 million across 2 funding rounds from investors including TechAviv, NFX and Vine Ventures. Remepy offers products and services including Hybrid Drugs and Therapeutic App. Remepy operates in a competitive market with competitors including Omda, MICA, Ataraxis, Significo and Kiro, among others.
- Headquarter United States
- Founders Michal Tsur
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Remepy, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Seed
May 01, 2024
-
Investors
TechAviv
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Remepy
Remepy offers a comprehensive portfolio of products and services, including Hybrid Drugs and Therapeutic App.
Drugs integrated with software to enhance effectiveness for various diseases.
App providing tailored interventions to support drug treatments.
People of Remepy
Unlock access to complete
Unlock access to complete
Funding Insights of Remepy
Remepy has successfully raised a total of $15M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $10 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Remepy
Remepy has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include TechAviv, NFX and Vine Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm offering funding and tools for startups in technology and investment sectors.
|
Locked | Locked | Locked | |
|
Venture capital investments are directed toward early-stage technology companies.
|
Locked | Locked | Locked | |
|
PsyMed Ventures is focused on funding mental health innovations.
|
Locked | Locked | Locked |
Investor details for Remepy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Remepy
Investment portfolio details for Remepy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Remepy
Detailed financials for Remepy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Remepy Comparisons
Peer comparison for Remepy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Remepy
Remepy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omda, MICA, Ataraxis, Significo and Kiro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regulatory and security compliant software solutions are provided by Omda.
|
|
| Locked | Locked | Locked |
AI-based decision support systems are provided for radiologists.
|
|
| Locked | Locked | Locked |
Provider of AI-based diagnostic platform
|
|
| Locked | Locked | Locked |
Software development services are provided by Significo in Austin.
|
|
| Locked | Locked | Locked |
AI development services for healthcare sectors are provided.
|
Detailed competitors of Remepy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remepy
Complete news archive for Remepy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Remepy
Remepy was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Remepy is headquartered in United States.
Remepy is a funded company, having raised a total of $15M across 2 funding rounds to date.
Remepy was established in 2022 in the United States as a provider of healthcare software application services. Operations are centered on delivering software solutions tailored to healthcare needs, including application development and support. The company is led by co-founder Michal Tsur. Services encompass various digital tools for healthcare providers, with a focus on efficiency in medical workflows. Geographic presence is maintained within the U.S. market.
Remepy's top competitors include Digital Autopsy, Ataraxis and MICA.
Remepy offers Hybrid Drugs and Therapeutic App.
Remepy has 10 investors. Key investors include TechAviv, NFX, Vine Ventures, PsyMed Ventures, and Firstime Ventures.